ASX HEALTH STOCKS: AFTER TGA APPROVAL IN AUSTRALIA, TELIX NOW GETS LICENSE TO SELL IN BRAZIL

© Stockhead Australia asx health caps TLX The ASX 200 Health Index (XHJ) is up by 0.80% at the time of writing, compared to the broader index which is down by 0.15%. Telix Pharmaceuticals (ASX:TLX) revealed this morning that Illucix has been granted exceptional authorisation for prostate cancer imaging in Brazil. This authorisation grants permission to commence the selling of Il...

Source: